Filing Details
- Accession Number:
- 0001209191-15-033980
- Form Type:
- 4
- Zero Holdings:
- No
- Publication Time:
- 2015-04-14 16:14:16
- Reporting Period:
- 2015-04-10
- Filing Date:
- 2015-04-14
- Accepted Time:
- 2015-04-14 16:14:16
- SEC Url:
- Form 4 Filing
Issuer
| Cik | Name | Symbol | Sector (SIC) | IRS No |
|---|---|---|---|---|
| 1293971 | Bluebird Bio Inc. | BLUE | Biological Products, (No Disgnostic Substances) (2836) | 000000000 |
Insiders
| Cik | Name | Reported Address | Insider Title | Director | Officer | Large Shareholder | Other |
|---|---|---|---|---|---|---|---|
| 1578251 | T. Jeffrey Walsh | C/O Bluebird Bio, Inc. 150 Second Street Cambridge MA 02141 | Chief Operating Officer | No | Yes | No | No |
Reported Non-Derivative Transactions
| Sec. Name | Acquisiton - Disposition | Date | Amount | Price | Remaning Holdings | Equity Swap Involved | Form Type | Code | Nature of Ownership | Explanation |
|---|---|---|---|---|---|---|---|---|---|---|
| Common Stock | Acquisiton | 2015-04-10 | 21,000 | $2.09 | 21,000 | No | 4 | M | Direct | |
| Common Stock | Disposition | 2015-04-10 | 1,760 | $124.82 | 19,240 | No | 4 | S | Direct | |
| Common Stock | Disposition | 2015-04-10 | 8,452 | $126.07 | 10,788 | No | 4 | S | Direct | |
| Common Stock | Disposition | 2015-04-10 | 10,788 | $126.55 | 0 | No | 4 | S | Direct |
| Equity Swap Involved | Form Type | Code | Nature of Ownership | Explanation |
|---|---|---|---|---|
| No | 4 | M | Direct | |
| No | 4 | S | Direct | |
| No | 4 | S | Direct | |
| No | 4 | S | Direct |
Reported Derivative Transactions
| Sec. Name | Sec. Type | Acquisiton - Disposition | Date | Amount | Price | Amount - 2 | Price - 2 |
|---|---|---|---|---|---|---|---|
| Common Stock | Stock Option (right to buy) | Disposition | 2015-04-10 | 21,000 | $0.00 | 21,000 | $2.09 |
| Remaning Holdings | Exercise Date | Expiration Date | Equity Swap Involved | Transaction Form Type | Transaction Code | Nature of Ownership |
|---|---|---|---|---|---|---|
| 58,307 | 2021-07-13 | No | 4 | M | Direct |
Footnotes
- The sales reported in this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted by the reporting person on September 26, 2014.
- The range of prices for the transaction reported on this line was $124.20 to $125.16. The average weighted price was $124.8174. The reporting person will provide, upon request by the SEC, the issuer or a security holder of the issuer, full information regarding the number of shares sold at each separate price.
- The range of prices for the transaction reported on this line was $125.29 to $126.29. The average weighted price was $126.0679. The reporting person will provide, upon request by the SEC, the issuer or a security holder of the issuer, full information regarding the number of shares sold at each separate price.
- The range of prices for the transaction reported on this line was $126.30 to $126.90. The average weighted price was $126.5526. The reporting person will provide, upon request by the SEC, the issuer or a security holder of the issuer, full information regarding the number of shares sold at each separate price.
- This option vests over a four-year period, at a rate of twenty-five percent (25%) on May 16, 2012 and in 36 equal monthly installments thereafter.
Billionaire Hedge Funds
